Last reviewed · How we verify

IlDong Pharmaceutical Co Ltd — Portfolio Competitive Intelligence Brief

IlDong Pharmaceutical Co Ltd pipeline: 3 marketed, 0 filed, 7 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 7 Phase 3 1 Phase 2 11 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
V - C+V - C V - C+V - C marketed Vitamin and mineral supplement Nutritional supplementation
V - C - C+V V - C - C+V marketed Inactivated viral vaccine Immunology / Infectious Disease
Besifovir dipivoxil Besifovir dipivoxil marketed Nucleotide reverse transcriptase inhibitor Hepatitis B virus reverse transcriptase Virology / Hepatology
Placebo for Hydrochlorothiazide Placebo for Hydrochlorothiazide phase 3 Cardiovascular
Placebo(for Rosuvastatin 20mg) Placebo(for Rosuvastatin 20mg) phase 3 Cardiovascular
Placebo(for Rosuvastatin 10mg) Placebo(for Rosuvastatin 10mg) phase 3
Placebo for Tamsulosin Placebo for Tamsulosin phase 3 Urology
Placebo(for Telmisartan 80mg) Placebo(for Telmisartan 80mg) phase 3 Cardiovascular
Telmisartan/Amlodipine+Hydrochlorothiazide Telmisartan/Amlodipine+Hydrochlorothiazide phase 3 Angiotensin II receptor antagonist, Calcium channel blocker, Thiazide diuretic Angiotensin II receptor, L-type calcium channel Cardiovascular
Experimental drug Experimental drug phase 3

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. GlaxoSmithKline · 2 shared drug classes
  2. Merck Sharp & Dohme LLC · 2 shared drug classes
  3. Boryung Pharmaceutical Co., Ltd · 1 shared drug class
  4. Centers for Disease Control and Prevention · 1 shared drug class
  5. Chiang Mai University · 1 shared drug class
  6. Children's Hospital Medical Center, Cincinnati · 1 shared drug class
  7. China National Biotec Group Company Limited · 1 shared drug class
  8. Bristol-Myers Squibb · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for IlDong Pharmaceutical Co Ltd:

Cite this brief

Drug Landscape (2026). IlDong Pharmaceutical Co Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ildong-pharmaceutical-co-ltd. Accessed 2026-05-16.

Related